---
title: "Pre-market hot trades in US stocks: Tharimmune up 10.12% pre-market; ALT5 Sigma up 7.65% pre-market"
description: "Tharimmune pre-market up 10.12%; ALT5 Sigma pre-market up 7.65%; Invivyd pre-market up 85.81%; Steakholder Foods pre-market up 79.80%; Beneficient pre-market up 53.57%"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/254584118.md"
published_at: "2025-08-26T09:07:40.000Z"
---

# Pre-market hot trades in US stocks: Tharimmune up 10.12% pre-market; ALT5 Sigma up 7.65% pre-market

> Tharimmune pre-market up 10.12%; ALT5 Sigma pre-market up 7.65%; Invivyd pre-market up 85.81%; Steakholder Foods pre-market up 79.80%; Beneficient pre-market up 53.57%

**Pre-market Hot Trades in US Stocks**

Tharimmune is up 10.12% in pre-market trading. Based on recent key news:

1.  On August 26, Tharimmune announced encouraging simulation results for its main clinical asset TH104, leading to a significant rise in stock price.
    
2.  On August 23, Tharimmune submitted a preliminary beneficial ownership statement to the SEC, confirming Thomas Clay Kahler as a company director, which was positively received by the market.
    
3.  On August 26, the market reacted to Powell's speech, affecting overall market sentiment.
    

ALT5 Sigma is up 7.65% in pre-market trading. Based on recent key news:

1.  On August 25, the company announced plans to enhance its portfolio in digital asset trading and payment solutions to align with the rapid development of the Web3 and cryptocurrency ecosystem. This strategic adjustment triggered a positive market response, driving the stock price up 7.65%.

**Top Gainers in Pre-market US Stocks**

Invivyd is up 85.81% in pre-market trading. Based on recent key news:

1.  On August 22, Invivyd announced the completion of its public offering, issuing 89,234,480 shares of common stock and raising approximately $57.5 million. This news significantly boosted the stock price.
    
2.  On August 22, underwriters exercised an additional purchase option, buying 14,423,076 shares of common stock, further enhancing market confidence.
    
3.  On August 22, the public offering price was set at $0.52 per share, with the pre-subscription warrant price at $0.5199 per share, attracting a large number of investors.
    

Beneficient is up 53.57% in pre-market trading. Based on recent key news:

1.  On August 23, Beneficient received a new delisting notice from Nasdaq for failing to submit its quarterly report for the period ending June 30, 2025. The company plans to apply for a hearing with the Nasdaq hearing panel and seek an extension. This news led to a 5.1% drop in stock price after hours.
    
2.  On August 23, Beneficient announced it received an additional Nasdaq listing decision notice.
    
3.  On August 22, Beneficient provided exit opportunities and primary capital solutions along with related trust and custodial services through its proprietary online platform

### Related Stocks

- [THAR.US - Tharimmune](https://longbridge.com/en/quote/THAR.US.md)
- [ALTS.US - ALT5 Sigma](https://longbridge.com/en/quote/ALTS.US.md)
- [CNTN.US - Canton Strategic](https://longbridge.com/en/quote/CNTN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Tharimmune Inc. Files Initial Beneficial Ownership Statement for Chief Operating Officer Angela Dominy Radkowski | Tharimmune Inc. has filed an initial beneficial ownership statement (Form 3) with the U.S. SEC, naming Angela Dominy Rad | [Link](https://longbridge.com/en/news/275667782.md) |
| Tharimmune Inc. Files Initial Statement of Beneficial Ownership for Director Jill E. Sommers | Tharimmune Inc. has filed an initial statement of beneficial ownership (Form 3) with the U.S. Securities and Exchange Co | [Link](https://longbridge.com/en/news/275667458.md) |
| Alt5 Sigma Appoints Tim Stanley as Independent Director and Audit Committee Member | Alt5 Sigma Corporation has appointed Tim Stanley as an independent director and member of its Audit Committee, effective | [Link](https://longbridge.com/en/news/275114278.md) |
| Alt5 Sigma Secures $15 Million Collateralized Loan from World Liberty Financial | Alt5 Sigma Corporation has secured a $15 million collateralized loan from World Liberty Financial LLC, with a 4.50% annu | [Link](https://longbridge.com/en/news/274504685.md) |
| BUZZ-Tharimmune rises after naming new chairman, COO | Shares of drug-developer Tharimmunerise 7.9% to $4.24 premarketCo says CEO Mark Wendland becomes chairman, replacing Vin | [Link](https://longbridge.com/en/news/275132618.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.